Suppr超能文献

血液系统恶性肿瘤中的髓源性抑制细胞:硬币的两面。

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin.

作者信息

Yu Shunjie, Ren Xiaotong, Li Lijuan

机构信息

Department of Hematology, Tianjin Medical University General Hospital, Heping district 154 Anshan Road, Tianjin, China.

出版信息

Exp Hematol Oncol. 2022 Jul 19;11(1):43. doi: 10.1186/s40164-022-00296-9.

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of bone marrow cells originating from immature myeloid cells. They exert potent immunosuppressive activity and are closely associated with the development of various diseases such as malignancies, infections, and inflammation. In malignant tumors, MDSCs, one of the most dominant cellular components comprising the tumor microenvironment, play a crucial role in tumor growth, drug resistance, recurrence, and immune escape. Although the role of MDSCs in solid tumors is currently being extensively studied, little is known about their role in hematologic malignancies. In this review, we comprehensively summarized and reviewed the different roles of MDSCs in hematologic malignancies and hematopoietic stem cell transplantation, and finally discussed current targeted therapeutic strategies.Affiliation: Kindly check and confirm the processed affiliations are correct. Amend if any.correct.

摘要

髓系来源的抑制细胞(MDSCs)是一类起源于未成熟髓样细胞的异质性骨髓细胞群体。它们具有强大的免疫抑制活性,与多种疾病(如恶性肿瘤、感染和炎症)的发生发展密切相关。在恶性肿瘤中,MDSCs是构成肿瘤微环境的最主要细胞成分之一,在肿瘤生长、耐药、复发和免疫逃逸中发挥着关键作用。尽管目前对MDSCs在实体瘤中的作用进行了广泛研究,但对其在血液系统恶性肿瘤中的作用却知之甚少。在本综述中,我们全面总结并回顾了MDSCs在血液系统恶性肿瘤和造血干细胞移植中的不同作用,最后讨论了当前的靶向治疗策略。单位信息:请检查并确认处理后的单位信息是否正确。如有错误请修改。正确。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/9295421/217c672db2d3/40164_2022_296_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验